• Pharmacy Author:
    Omudhome Ogbru, PharmD

    Dr. Ogbru received his Doctorate in Pharmacy from the University of the Pacific School of Pharmacy in 1995. He completed a Pharmacy Practice Residency at the University of Arizona/University Medical Center in 1996. He was a Professor of Pharmacy Practice and a Regional Clerkship Coordinator for the University of the Pacific School of Pharmacy from 1996-99.

  • Medical and Pharmacy Editor: William C. Shiel Jr., MD, FACP, FACR
    William C. Shiel Jr., MD, FACP, FACR

    William C. Shiel Jr., MD, FACP, FACR

    Dr. Shiel received a Bachelor of Science degree with honors from the University of Notre Dame. There he was involved in research in radiation biology and received the Huisking Scholarship. After graduating from St. Louis University School of Medicine, he completed his Internal Medicine residency and Rheumatology fellowship at the University of California, Irvine. He is board-certified in Internal Medicine and Rheumatology.

Bacterial Infections 101 Pictures Slideshow

DOSING: The recommended dose for adults is 200-400 mg every 12 hours.

DRUG INTERACTIONS: Probenecid (Benemid) may increase the concentration of loracarbef in the blood by decreasing excretion of loracarbef by the kidney. This interaction is sometimes used to enhance the effect of cephalosporins.

PREGNANCY: Safe use during pregnancy has not been established.

NURSING MOTHERS: Safe use in nursing mothers has not been established.

SIDE EFFECTS: Loracarbef is generally well tolerated, and side effects are usually transient. More common side effects include nausea, abdominal pain, vomiting, skin rash, abnormal liver tests, vaginitis, itching, headaches, and dizziness.

Loracarbef should be avoided by patients with a known allergy to other cephalosporin antibiotics. Since loracarbef is chemically related to penicillin, an occasional patient can have an allergic reaction (sometimes even life threatening anaphylaxis) to both medications. Treatment with loracarbef and other antibiotics can alter the normal bacteria flora of the colon and permit overgrowth of the bacterium, Clostridium difficile, in the colon. This may lead to inflammation of the colon known as C. difficile or pseudo-membranous colitis. Patients who develop pseudo-membranous colitis as a result of antibiotic treatment can experience diarrhea, abdominal pain, fever, and sometimes even shock.

Reference: FDA Prescribing Information

Medically Reviewed by a Doctor on 10/28/2014

Quick GuideInfectious Mononucleosis (Mono): Symptoms and Treatment

Infectious Mononucleosis (Mono): Symptoms and Treatment
FDA Logo

Report Problems to the Food and Drug Administration

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

See more info: loracarbef on RxList
RxList Logo

Need help identifying pills and medications?

Use the pill identifier tool on RxList.

Subscribe to MedicineNet's Newsletters

Get the latest health and medical information delivered direct to your inbox!

By clicking Submit, I agree to the MedicineNet's Terms & Conditions & Privacy Policy and understand that I may opt out of MedicineNet's subscriptions at any time.

Health Solutions From Our Sponsors